title: Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation.
abstract: Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.
authors.affiliation: Washington University School of Medicine, Department of Internal Medicine, Division of Bone Marrow Transplantation, St Louis, MO 63110, USA.
authors.forename: D
authors.initials: D
authors.lastname: Adkins
authors.forename: R
authors.initials: R
authors.lastname: Brown
authors.forename: L T
authors.initials: LT
authors.lastname: Goodnough
authors.forename: H
authors.initials: H
authors.lastname: Khoury
authors.forename: W
authors.initials: W
authors.lastname: Popovic
authors.forename: J
authors.initials: J
authors.lastname: DiPersio
mesh_terms: D016026:Bone Marrow Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous